Company / Current Liabilities
BeOne Medicines Ltd. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$1.8B
FY2025
5-year range
$1.5B / $2.2B
FY2021-FY2025
Trend
-17.4%
vs FY2024
Sector context
#19 of 213
Health Care
What the data says
Among 213 Health Care companies, BeOne Medicines Ltd. is in the bottom 9% for current liabilities. Current Liabilities has fluctuated over the past 10 years, ranging from $35M in FY2016 to $2.2B in FY2024.
Based on SEC 10-K filings.
$1.8B in FY2025 with a 5-year CAGR of +11.2%. Top quartile in the Health Care sector.
Remained stable around $1.8B over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +7.6%
- 5-Year CAGR
- +11.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 213This company $1.8B Sector average $1.6B
▼
+15.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +11.2%, indicating consistent growth.
- In FY2025, current liabilities decreased 17.4% year-over-year.
- Ranks #19 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.8B | -17.4% |
| FY2024 | $2.2B | +22.4% |
| FY2023 | $1.8B | +23.3% |
| FY2022 | $1.5B | -8.2% |
| FY2021 | $1.6B | +48.8% |
| FY2020 | $1.1B | +246.5% |
| FY2019 | $310.3M | +25.9% |
| FY2018 | $246.5M | +64.3% |
| FY2017 | $150.0M | +327.8% |
| FY2016 | $35.1M | -0.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026